100 Years of Immunotherapy: The Monaco Charter

Publisher: Karger

E-ISSN: 1423-0097|160|4|346-349

ISSN: 1018-2438

Source: International Archives of Allergy and Immunology, Vol.160, Iss.4, 2012-11, pp. : 346-349

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Aims of the Monaco Charter: (1) to present the current evidence on the efficacy and safety of allergen-specific immunotherapy (SIT) and to address the reasons for its underuse in clinical practice; (2) to develop strategies to increase the awareness about the benefits and the hazards of SIT in allergic patients, lay public and healthcare professionals not trained in allergy, and (3) to make SIT accessible and affordable to eligible patients.